Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex
Marie Woelfer, Meng Li, Lejla Čolić, et al.
The World Journal of Biological Psychiatry (2019) Vol. 21, Iss. 9, pp. 696-710
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 165
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 461-466
Open Access | Times Cited: 100
Polyphenols selectively reverse early-life stress-induced behavioural, neurochemical and microbiota changes in the rat
Francisco Donoso, Sian Egerton, Thomaz F. S. Bastiaanssen, et al.
Psychoneuroendocrinology (2020) Vol. 116, pp. 104673-104673
Open Access | Times Cited: 71
The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity
Melody J.Y. Kang, Emily R. Hawken, Gustavo Vázquez
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 29
Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer’s disease
Simone Eggert, Stefan Kins, Kristina Endres, et al.
Biological Chemistry (2021) Vol. 403, Iss. 1, pp. 43-71
Open Access | Times Cited: 34
Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression
Ethan Ponton, Gustavo Turecki, Corina Nagy
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 75-84
Open Access | Times Cited: 34
Exploring the Different Impacts of Ketamine on Neurotrophic Factors and Inflammatory Parameters in a Cecal Ligation and Puncture-Induced Sepsis Model
Jorge M. Aguiar‐Geraldo, Lara Canever, Debora P. Marino, et al.
Neurotoxicity Research (2025) Vol. 43, Iss. 1
Closed Access
Exploring the impact of exercise-induced BDNF on neuroplasticity in neurodegenerative and neuropsychiatric conditions
Mega O. Oyovwi, Ugushida Thankgod Ogenma, Anthonia Onyenweny
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD
Nathan Wellington, Ana Paula Bouças, Jim Lagopoulos, et al.
Psychopharmacology (2025)
Open Access
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106132-106132
Open Access
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019
John Corkery, Wan-Chu Hung, Hugh Claridge, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 11, pp. 1324-1348
Open Access | Times Cited: 31
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Neurobiological biomarkers of response to ketamine
Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, et al.
Advances in pharmacology (2020), pp. 195-235
Open Access | Times Cited: 29
Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression
Wei Zheng, Li-Mei Gu, Chen-Hui Sun, et al.
Journal of Affective Disorders (2021) Vol. 300, pp. 109-113
Closed Access | Times Cited: 23
Brain region–specific roles of brain-derived neurotrophic factor in social stress–induced depressive-like behavior
Man Yong Han, Deyang Zeng, Wei Tan, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 159-173
Open Access | Times Cited: 3
Targeting glucocorticoid receptor signaling pathway for treatment of stress-related brain disorders
Tansu Göver, Michał Ślęzak
Pharmacological Reports (2024)
Open Access | Times Cited: 3
Association of Lifestyle Activities with Functional Brain Connectivity and Relationship to Cognitive Decline among Older Adults
Anja Soldan, Corinne Pettigrew, Yuxin Zhu, et al.
Cerebral Cortex (2021) Vol. 31, Iss. 12, pp. 5637-5651
Open Access | Times Cited: 22
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling
Stephen M. Stahl, Sara De Martin, Andrea Mattarei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12196-12196
Open Access | Times Cited: 15
Sex differences in effects of tDCS and language treatments on brain functional connectivity in primary progressive aphasia
Abigail Licata, Yi Zhao, Olivia Herrmann, et al.
NeuroImage Clinical (2023) Vol. 37, pp. 103329-103329
Open Access | Times Cited: 8
Circadian rhythm of brain‐derived neurotrophic factor in serum and plasma
M. Ehrhardt, Stefanie Schreiber, Yves Duderstadt, et al.
Experimental Physiology (2024) Vol. 109, Iss. 10, pp. 1755-1767
Open Access | Times Cited: 2
The Compelling Role of Brain‐Derived Neurotrophic Factor Signaling in Multiple Sclerosis: Role of BDNF Activators
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access | Times Cited: 2
Functional connectivity changes between amygdala and prefrontal cortex after ECT are associated with improvement in distinct depressive symptoms
Ann‐Kathrin Domke, Moritz Hempel, Corinna Hartling, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1489-1499
Open Access | Times Cited: 6
Ketamine’s modulation of cerebro-cerebellar circuitry during response inhibition in major depression
Joana Loureiro, Ashish Sahib, Megha Vasavada, et al.
NeuroImage Clinical (2021) Vol. 32, pp. 102792-102792
Open Access | Times Cited: 15
The resurgence of hallucinogen drugs in clinical research
Maria Teresa Rivera-Garcia, Silvia L. Cruz
Revista de investigaci�n Cl�nica (2023) Vol. 75, Iss. 3
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top